Amit Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amit Kumar has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Paul B. Fisher
Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, Virginia, USA
17 shared publications - Devanand Sarkar
Department of Cellular, Molecular and Genetic Medicine, Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA
15 shared publications - Praveen Bhoopathi
Department of Human and Molecular Genetics, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA
15 shared publications - Swadesh K. Das
VCU Institute of Molecular Medicine, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA
15 shared publications - Xiang-Yang Wang
Department of Human & Molecular Genetics, School of Medicine, Virginia Commonwealth University, Richmond, VA, 23298, United States
15 shared publications - Chunqing Guo
Department of Human & Molecular Genetics, Virginia Commonwealth University School of Medicine, PO BOX 980033, Richmond VA23298, USA
14 shared publications
Latest Publications
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S7 from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
IVMT-Rx-3 suppressed tumor cell derived pro-inflammatory cytokines expression.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S7 from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
IVMT-Rx-3 suppressed tumor cell derived pro-inflammatory cytokines expression.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S6 from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
IVMT-Rx-3 inhibited invasion in murine melanoma cells
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S6 from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
IVMT-Rx-3 inhibited invasion in murine melanoma cells
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S3 from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
MDA-9 downregulation impacted the invasiveness of patient derived melanoma cells
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S3 from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
MDA-9 downregulation impacted the invasiveness of patient derived melanoma cells
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S8 from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
Comparative effects of DMSO and IVMT-Rx-3 on Treg populations
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S8 from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
Comparative effects of DMSO and IVMT-Rx-3 on Treg populations
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S4 from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
PDZ1i was outperformed by IVMT-Rx-3
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S4 from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
PDZ1i was outperformed by IVMT-Rx-3
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S2 from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S2 from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S5 from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
IVMT-Rx-3 inhibited MDA-9/Src signaling cascade
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S5 from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
IVMT-Rx-3 inhibited MDA-9/Src signaling cascade
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S1 from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S1 from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
Supplementary Information for IVMT-Rx-3 Synthesis
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis
Supplementary Information for IVMT-Rx-3 Synthesis